| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |